RT Journal Article
SR Electronic
T1 Prediction of COVID-19 Spreading Profiles in South Korea, Italy and Iran by Data-Driven Coding
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.08.20032847
DO 10.1101/2020.03.08.20032847
A1 Choujun Zhan
A1 Chi K. Tse
A1 Zhikang Lai
A1 Tianyong Hao
A1 Jingjing Su
YR 2020
UL http://medrxiv.org/content/early/2020/03/10/2020.03.08.20032847.abstract
AB This work applies a data-driven coding method for prediction of the COVID-19 spreading profile in any given population that shows an initial phase of epidemic progression. Based on the historical data collected for COVID-19 spreading in 367 cities in China and the set of parameters of the augmented Susceptible-Exposed-Infected-Removed (SEIR) model obtained for each city, a set of profile codes representing a variety of transmission mechanisms and contact topologies is formed. By comparing the data of an early outbreak of a given population with the complete set of historical profiles, the best fit profiles are selected and the corresponding sets of profile codes are used for prediction of the future progression of the epidemic in that population. Application of the method to the data collected for South Korea, Italy and Iran shows that peaks of infection cases are expected to occur before the end of March 2020, and that the percentage of population infected in each city will be less than 0.01%, 0.05% and 0.02%, for South Korea, Italy and Iran, respectively.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Science Foundation of China Project 61703355, Guangdong Youth University Innovative Talents Project 2016KQNCX223, and City University of Hong Kong under Special Fund 9380114.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript will be made available upon request. Updated daily COVID-19 infection data are available from WHO at https://www.who.int/emergencies/diseases/novel-coronavirus-2019 https://www.who.int/emergencies/diseases/novel-coronavirus-2019 https://en.wikipedia.org/wiki2020\_coronavirus\_outbreak\_in\_South\_Korea